Cryselle
Product Images NDC 68788-8442

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 68788-8442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cryselle Tablets 03mg003mg (22e5d50a A772 4e90 82f8 B49ecdf91610 00)

Label for Cryselle Tablets 0.3mg/0.03mg, by Preferred Pharmaceuticals Inc. The label includes the brand name and strength in large text on a yellow background, with instructions to take as directed in English and Spanish. It indicates the manufacturer as Teva Pharmaceuticals USA Inc and a caution about the prescription drug transfer. The label also has QR and bar codes present.*

FDA Label Image

Norgestrel Strustural Formula (Image 1)

Chemical structure of the active ingredient in Cryselle, showing a steroid-like backbone with specific functional groups including a ketone and an ethynyl group on the cyclopentane ring.*

FDA Label Image

Ethinyl Estradiol Structural Formula (Image 2)

Chemical structure of the active ingredient associated with Cryselle, showing a complex steroidal molecular framework with hydroxyl and acetylene functional groups.*

FDA Label Image

1 (Image 3)

A forest plot comparing effect estimates of ever combined oral contraceptive (COC) use versus never use and current COC use versus never use across multiple cohort studies. The plot includes odds ratios (OR), relative risks (RR), and hazard ratios (HR) with 95% confidence intervals, visualized as data points and horizontal error bars along a horizontal axis labeled 'Effect Estimate' ranging approximately from -1.5 to 2.0.*

FDA Label Image

Chart 1 (Image 4)

A vertical chart comparing pregnancy rates per 100 women in one year with different birth control methods. The chart ranges from fewer than 1 pregnancy to 85 or more pregnancies, listing methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, fertility awareness methods, spermicides, withdrawal, and no birth control.*

FDA Label Image

1 (Image 5)

Cryselle oral contraceptive 28-pill pack blister card with a 28-day supply, containing both white tablets and light-green colored tablets. The card is labeled with days of the week, storage instructions at 20° to 25°C (68° to 77°F), and the labeler Preferred Pharmaceuticals Inc.*

FDA Label Image

Pick Correct Day Label Blister Image (Image 6)

Illustration showing how to apply the correct day label to a Cryselle 28-day oral contraceptive tablet pack. The image depicts a hand peeling a day label (Thursday to Wednesday) to place on the tablet pack, which contains four rows of circular tablets with days marked above each column.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.